Latest Articles
Myelofibrosis Trials: Diverging Narratives on Enrollment, Endpoint Clarity, and Safety Data - AInvest
Myelofibrosis Trials: Diverging Narratives on Enrollment, Endpoint Clarity, and Safety Data AInvest
Published: Aug. 11, 2025, 3:12 p.m.
Activated eosinophil plays a role in promoting fibrosis in endometriotic lesion - Nature
Activated eosinophil plays a role in promoting fibrosis in endometriotic lesion Nature
Published: July 31, 2025, 9:03 p.m.
CCN5 negatively regulates TGF-β-induced endometriosis associated fibrosis through Wnt/β-catenin signaling via Smad3-dependent mechanism - Journal of Translational Medicine
CCN5 negatively regulates TGF-β-induced endometriosis associated fibrosis through Wnt/β-catenin signaling via Smad3-dependent mechanism Journal of Translational Medicine
Published: July 10, 2025, 7:44 a.m.
XBP1 promoted EMT and fibrosis in endometrial epithelial cells. (a)... - researchgate.net
XBP1 promoted EMT and fibrosis in endometrial epithelial cells. (a)... researchgate.net
Published: July 9, 2025, 7:31 p.m.
Radiomics analysis based on T2-weighed imaging and T2 mapping for staging endometrial fibrosis - Nature
Radiomics analysis based on T2-weighed imaging and T2 mapping for staging endometrial fibrosis Nature
Published: July 8, 2025, 9:36 a.m.
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion - Nature
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion Nature
Published: July 2, 2025, 5:48 a.m.
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion - nature.com
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion nature.com
Published: July 2, 2025, 5:48 a.m.
Endothelial senescence induced by PAI-1 promotes endometrial fibrosis - Nature.com
Endothelial senescence induced by PAI-1 promotes endometrial fibrosis Nature.com
Published: March 6, 2025, 5:36 p.m.
Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress - MSN
Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress MSN
Published: Feb. 21, 2025, 12:07 p.m.
TRα1 mutant suppresses KLF9 to cause endometrial metaplasia with ectopic IL-33 expression leading to uterine fibrosis and infertility - Nature.com
TRα1 mutant suppresses KLF9 to cause endometrial metaplasia with ectopic IL-33 expression leading to uterine fibrosis and infertility Nature.com
Published: Jan. 31, 2025, 1:21 p.m.
Link copied to clipboard!